CNCE - Concert Pharmaceuticals Inc
Previous close
8.37
0 0%
Share volume: 0
Last Updated: Fri 03 Mar 2023 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$8.37
0.00
0.00%
Summary score
25%
Profitability
25%
Dept financing
5%
Liquidity
41%
Performance
25%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.37%
Return on assets
-5.49%
Return on sales
0%
Return on invested capital
-181.68%
Total debt ratio
16.29%
Debt ratio change over timeo
-1.02%
Current Ratio
20.47%
Quick Ratio
0%
Cash Position Ratio
4.87%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.22%
Return on assets
-11.21%
Return on sales
0%
Return on invested capital
-390.61%
Total debt ratio
20.36%
Debt ratio change over timeo
-1.08%
Current Ratio
11.06%
Quick Ratio
0%
Cash Position Ratio
2.89%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-9.02%
Return on assets
-7.63%
Return on sales
0%
Return on invested capital
-165.72%
Total debt ratio
16.23%
Debt ratio change over time
-1.03%
Current Ratio
16.07%
Quick Ratio
0%
Cash Position Ratio
2.82%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-97.16%
Return on assets
-97.48%
Return on sales
0%
Return on invested capital
-56.71%
Total debt ratio
-102.26%
Debt ratio change over time
-1.02%
Current Ratio
-2.96%
Quick Ratio
0%
Cash Position Ratio
-1.47%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CNCE | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -7.37% | 0% | 0% | 29.06% |
| Return on assets | -5.49% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | -181.68% | 0% | 0% | 47.78% |
| Profitability | 25% | 0% | 25% | 50% |
| Total debt ratio | 16.29% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.02% | 0% | 0% | 19.02% |
| Dept financing | 2% | 0% | 0% | 50% |
| Current Ratio | 11.06% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.89% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 50% |
| Short-term ratios | CNCE | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -14.22% | 0% | 0% | -16.12% |
| Return on assets | -11.21% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | -390.61% | 0% | 0% | 96.56% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 20.36% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.08% | 0% | 0% | 0.09% |
| Dept financing | 6% | 0% | 0% | 50% |
| Current Ratio | 11.06% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.89% | 0% | 0% | 5.68% |
| Liquididy | 38% | 0% | 0% | 63% |